Mitochondrial signaling pathways and their role in cancer drug resistance
Cellular Signalling,
Journal Year:
2024,
Volume and Issue:
122, P. 111329 - 111329
Published: Aug. 5, 2024
Language: Английский
DNA tetrahedron nanomedicine for enhanced antitumor and antimetastatic effect through the amplification of mitochondrial oxidative stress
Zixuan Chen,
No information about this author
Zhaoyan Tian,
No information about this author
Yafeng Wu
No information about this author
et al.
Acta Biomaterialia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
Regulated cell death mechanisms in mitochondria-targeted phototherapy
Qihang Ding,
No information about this author
Hyeonji Rha,
No information about this author
Changyu Yoon
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
unknown, P. 113720 - 113720
Published: April 1, 2025
Language: Английский
Unlocking the Potential of Disulfidptosis: Nanotechnology‐Driven Strategies for Advanced Cancer Therapy
Small,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 24, 2025
Abstract
Tumor
tissues
exhibit
elevated
oxidative
stress,
with
the
cystine‐glutamate
transporter
x
CT
solute
carrier
family
7
member
11
(
CT/SLC7A11)
protecting
cancer
cells
from
damage
by
facilitating
cystine
uptake
for
glutathione
synthesis.
Disulfidptosis,
a
newly
identified
form
of
programmed
cell
death
(PCD),
occurs
in
high
CT/SLC7A11
expression
under
glucose‐deprived
conditions.
Distinct
other
PCD
pathways,
disulfidptosis
is
characterized
aberrant
disulfide
bond
formation
and
cellular
dysfunction,
ultimately
resulting
death.
This
novel
mechanism
offers
remarkable
therapeutic
potential
targeting
inherent
stress
vulnerabilities
rapidly
growing
cells.
Advances
nanotechnology
enable
development
nanomaterials
capable
inducing
reactive
oxygen
species
(ROS)
generation,
disrupting
bonds.
In
addition,
they
are
to
deliver
agents
directly
tumors,
thereby
improving
precision
minimizing
off‐target
effects.
Moreover,
combining
ROS‐induced
immunogenic
can
remodel
tumor
microenvironment
enhance
anti‐tumor
immunity.
review
explores
mechanisms
underlying
disulfidptosis,
its
treatment,
synergistic
role
amplifying
Selective
induction
using
represents
promising
strategy
achieving
more
effective,
selective,
less
toxic
therapies.
Language: Английский
Twisted‐Planar Molecular Engineering with Sonication‐Induced J‐Aggregation to Design Near‐Infrared J‐Aggregates for Enhanced Phototherapy
Yubo Liu,
No information about this author
Yuchen Song,
No information about this author
Zhong‐Hong Zhu
No information about this author
et al.
Angewandte Chemie International Edition,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 11, 2024
J-aggregates
show
great
promise
in
phototherapy,
but
are
limited
to
specific
molecular
skeletons
and
poor
self-assembly
controllability.
Herein,
we
report
a
twisted-planar
strategy
with
sonication-induced
J-aggregation
develop
donor-acceptor
(D-A)
type
for
phototherapy.
With
propeller
aggregation-induced
emission
(AIE)
moieties
as
the
twisted
subunits
thiophene
planar
π-bridge,
optimal
π-interaction
MTSIC
induces
appropriate
slip
angle
formation,
redshifting
absorption
from
624
nm
790
nm.
In
contrast,
shorter
π-planarity
results
amorphous
aggregates,
elongation
promotes
charge
transfer
(CT)
coupled
J-aggregates.
Sonication
was
demonstrated
be
effective
controlling
behaviors
of
MTSIC,
which
enables
transformation
aggregates
H-intermediates,
finally
stable
After
encapsulation
lipid-PEG,
resultant
J-dots
enhanced
phototherapeutic
effects
over
dots,
including
brightness,
reactive
oxygen
species
(ROS)
generation,
photothermal
conversion,
delivering
superior
cancer
phototherapy
performance.
This
work
not
only
advances
D-A
design
also
provides
promising
supramolecular
assembly
development.
Language: Английский
Twisted‐Planar Molecular Engineering with Sonication‐Induced J‐Aggregation to Design Near‐Infrared J‐Aggregates for Enhanced Phototherapy
Yubo Liu,
No information about this author
Yuchen Song,
No information about this author
Zhong‐Hong Zhu
No information about this author
et al.
Angewandte Chemie,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 11, 2024
Abstract
J‐aggregates
show
great
promise
in
phototherapy,
but
are
limited
to
specific
molecular
skeletons
and
poor
self‐assembly
controllability.
Herein,
we
report
a
twisted‐planar
strategy
with
sonication‐induced
J‐aggregation
develop
donor–acceptor
(D–A)
type
for
phototherapy.
With
propeller
aggregation‐induced
emission
(AIE)
moieties
as
the
twisted
subunits
thiophene
planar
π‐bridge,
optimal
π‐interaction
MTSIC
induces
appropriate
slip
angle
formation,
redshifting
absorption
from
624
nm
790
nm.
In
contrast,
shorter
π‐planarity
results
amorphous
aggregates,
elongation
promotes
charge
transfer
(CT)
coupled
J‐aggregates.
Sonication
was
demonstrated
be
effective
controlling
behaviors
of
MTSIC,
which
enables
transformation
aggregates
H‐intermediates,
finally
stable
After
encapsulation
lipid‐PEG,
resultant
J‐dots
enhanced
phototherapeutic
effects
over
dots,
including
brightness,
reactive
oxygen
species
(ROS)
generation,
photothermal
conversion,
delivering
superior
cancer
phototherapy
performance.
This
work
not
only
advances
D–A
design
also
provides
promising
supramolecular
assembly
development.
Language: Английский